Tag Archives: Astellas Pharma Inc.

Pfizer Wins Bidding War for Medivation; But Why Bother?

Pharmaceutical giant Pfizer Inc. (New York City) is paying $14 billion to buy Medivation Inc. (San Francisco), a biotech company that sells a high-priced prostate cancer medication discovered by UCLA, according to the… Read more »

First False Claims Act Settlement Turns on Cancer-Drug Survival Data

In the first False Claims Act settlement that turns on cancer-drug survival data, Roche Holding AG’s (Basel CHE) Genentech unit and OSI Pharmaceuticals LLC (Farmingdale NY) agreed to pay $67… Read more »